Kevin Bitterman

Kevin J. Bitterman, Ph.D. is a Principal at Polaris Venture Partners. Kevin joined Polaris in 2004 and focuses on investments in the life sciences. Prior to joining Polaris, Kevin completed his Ph.D. in genetics at Harvard Medical School. His...

Affiliation: Unaffiliated

Updated on Nov 7, 2013
Kevin Bitterman at CrunchBase
Editas Medicine CEO
Sirtris Pharmaceuticals Co-founder
Genocea Biosciences Co-founder
TARIS Biomedical Director
Parasol Therapeutics Co-founder
Follica Director
Parasol Therapeutics Director
Pulmatrix Board Observer
Neuronetics Board of Directors
Polaris Partners Principal
Biolex Therapeutics Director
Genocea Biosciences Director
Solace Therapeutics Director
Kala Pharmaceuticals Board Of Directors